Nuveen Asset Management, LLC Pliant Therapeutics, Inc. Transaction History

Nuveen Asset Management, LLC

$345 Billion
Q3 2024

A detailed history of Nuveen Asset Management, LLC transactions in Pliant Therapeutics, Inc. stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 335,480 shares of PLRX stock, worth $4.13 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

335,480

Previous 193,129 73.71%

Holding current value

$4.13 Million

Previous $2.08 Million 81.12%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$10.52 - $14.35 $1.5 Million - $2.04 Million	142,351 Added 73.71%	335,480 $3.76 Million
Q2 2024 Aug 09, 2024	SELL	$10.58 - $15.61 $198,914 - $293,483	-18,801 Reduced 8.87%	193,129 $2.08 Million
Q1 2024 May 13, 2024	BUY	$14.14 - $19.59 $299,683 - $415,190	21,194 Added 11.11%	211,930 $3.16 Million
Q4 2023 Feb 14, 2024	SELL	$12.85 - $19.15 $241,669 - $360,154	-18,807 Reduced 8.98%	190,736 $3.45 Million
Q3 2023 Nov 14, 2023	BUY	$14.58 - $20.15 $9,549 - $13,198	655 Added 0.31%	209,543 $3.63 Million
Q2 2023 Aug 14, 2023	BUY	$18.12 - $30.56 $2.91 Million - $4.91 Million	160,728 Added 333.74%	208,888 $3.79 Million
Q1 2023 May 15, 2023	BUY	$18.73 - $36.26 $92,488 - $179,051	4,938 Added 11.42%	48,160 $1.28 Million
Q4 2022 Feb 14, 2023	BUY	$17.0 - $25.43 $734,774 - $1.1 Million	43,222 New	43,222 $835,000
Q2 2022 Aug 15, 2022	SELL	$4.11 - $8.75 $336,296 - $715,960	-81,824 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$7.01 - $14.1 $49,925 - $100,420	-7,122 Reduced 8.01%	81,824 $619,000
Q4 2021 Feb 14, 2022	SELL	$12.27 - $18.26 $51,288 - $76,326	-4,180 Reduced 4.49%	88,946 $1.2 Million
Q3 2021 Nov 12, 2021	SELL	$16.48 - $28.98 $277,045 - $487,182	-16,811 Reduced 15.29%	93,126 $1.57 Million
Q2 2021 Aug 16, 2021	BUY	$28.05 - $37.69 $831,963 - $1.12 Million	29,660 Added 36.95%	109,937 $3.2 Million
Q1 2021 May 17, 2021	BUY	$24.52 - $40.23 $1.4 Million - $2.3 Million	57,172 Added 247.44%	80,277 $3.16 Million
Q3 2020 Nov 16, 2020	BUY	$21.54 - $29.53 $497,681 - $682,290	23,105 New	23,105 $523,000

Others Institutions Holding PLRX

# of Institutions

168

Shares Held

63.2M

Call Options Held

245K

Put Options Held

373K

View Full List

About PLIANT THERAPEUTICS, INC.

Ticker PLRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,682,000
Market Cap $600M
Description
Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a tri...

More about PLRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.

Account

Nuveen Asset Management, LLC Pliant Therapeutics, Inc. Transaction History